Prevention of post-traumatic stress symptoms (PTSS) in healthcare workers (HCWs) facing
the current COVID-19 pandemic is a challenge worldwide as HCWs are likely to experience …

An acute respiratory syndrome (COVID-19), caused by a novel coronavirus (SARS-CoV-2)
with a high rate of morbidity and elevate mortality, has emerged as one of the most important …

Background Ceftazidime-avibactam (CAZ-AVI) has been approved in Europe for the
treatment of complicated intra-abdominal and urinary tract infections, as well as hospital-acquired …

Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has
been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal …

Coronavirus 2019 (COVID-19) is a pandemic associated with a high risk of mortality. Human
serum albumin (HSA) is an acute phase reactant with antioxidant property; however, its …

Background Post-traumatic stress disorder (PTSD) is a severe but treatable mental disorder
that develops after a life-threatening traumatic event. Coronavirus disease 19 (COVID-19) …

Objectives Superinfections in patients hospitalized in intensive care unit (ICU) are an
important and challenging complication, also in COVID-19. However, no definitive data are …

The severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) global pandemic is a
devastating event that is causing thousands of victims every day around the world. One of the …

Nox2 is responsible for artery dysfunction via production of reactive oxidant species. RNA
viruses may activate Nox2, but it is unknown if this occurs in coronavirus 2019(Covid-19). …

Background A growing body of observational evidence supports the value of ceftazidime-avibactam
(CAZ-AVI) in managing infections caused by carbapenem-resistant …